CRISPR cancer

CRISPR update: lots of new pubs, news, & maybe a patent finale

Figure-1a-from-Akcakaya-et-al.-paper-Nature-2018

Sometimes it seems like a bunch of stuff in one area, like with CRISPR this week, happens all of a sudden in science. A bunch of fairly high-profile gene editing pubs came out. They generated a lot of news reports. Other news in this arena popped up too, all within a few days. In vivo …

CRISPR update: lots of new pubs, news, & maybe a patent finale Read More »

TGIF weekend reads: senolytics, new CRISPR, stem cells, & 3 wacky things

Mulas-et-al.-Development

Over the weekends I try to catch up on more diverse reading and sometimes come up with a list of stuff I want to get to during this time, but I also put together weekend reads usually on Fridays as a kind of TGIF on The Niche for the wider audience here. So here’s the …

TGIF weekend reads: senolytics, new CRISPR, stem cells, & 3 wacky things Read More »

Could Cancer Risk Claw CRISPR’s Potential? Some Balanced Perspectives

Cancer-CRISPR

Could potential associated cancer risks claw into CRISPR’s potential? The short answer from both previous and new data is that while CRISPR gene editing impacts the P53 pathway, which is involved in cancer along with having many other functions, this news is neither too surprising nor a fatal flaw, but some caution is warranted. CRISPR …

Could Cancer Risk Claw CRISPR’s Potential? Some Balanced Perspectives Read More »